Congenica Expands in North America with Strategic Appointment Shikha O’Brien, Chief Business Officer Genomics Analysis Leader Appoints Dr Shikha O’Brien as Chief Business Officer 16th January 2017, Cambridge UK Congenica, a world leading developer of genome analysis and interpretation technologies, expands its operations in the US with the announcement that it has recruited Dr Shikha... Read more
Download PDF Read more
London – 11 January 2017 – Bringing ultrasound care into every setting in any environment around the globe1, GE Healthcare today unveiled its new generation of pocket-sized, dual-probe ultrasound, the Vscan Extend™2. From the hospital and ambulance to more rural environments1, Vscan Extend™ uses incredible image quality and wireless connectivity3 to help users increase clinical... Read more
2017 2017/01/11 Announcement on submission of the Clinical Trial Plan Notification for phase I/II clinical trial of CAR gene therapy in Japan Kusatsu/Shiga, Japan — January 11, 2017 —Takara Bio Inc. (Takara Bio), today announced that it has submitted the Clinical Trial Notification for regenerative medicines to PMDA (Pharmaceuticals and Medical Devices Agency), Japanese regulatory... Read more
WASHINGTON, D.C. MINNEAPOLIS, MN – January 9, 2017 – The COPD Foundation-sponsored COPD Biomarker Qualification Consortium (CBQC) today announced that it has partnered with the Bio-Techne Corporation, a manufacturer of biotechnology products for life science research and diagnostics. The partnership was established to evaluate the suitability of a soluble form of receptor for advanced glycation... Read more
STORY HIGHLIGHTS New Edico Genome bundle offers a pre-configured, out-of-the-box solution for rapid analysis and efficient storage of next-generation sequencing data. Available now, the solution allows for simple implementation for users while reducing storage costs, speeding analysis and maintaining high accuracy. Bundle enables analysis of a whole genome in as little as 22 minutes, which... Read more
Agilent fortifies its target-enrichment portfolio through its planned acquisition of Multiplicom N.V. SANTA CLARA, Calif. & NIEL, Belgium–(BUSINESS WIRE)–Dec. 20, 2016– Agilent Technologies Inc. (NYSE:A) and Multiplicom N.V. today announced that they have signed a definitive agreement under which Agilent will acquire Multiplicom, a leading European diagnostics company with state-of-the-art genetic testing technology and products.... Read more
Takara Bio Signs Exclusive License Agreement with Otsuka for the Investigational Cancer Treatment HF10, an Oncolytic Virus Kusatsu/Shiga, Japan — December 15, 2016 — Takara Bio Inc. (Takara) announced today that it has entered into an exclusive license agreement with Otsuka Pharmaceutical Co., Ltd. (Otsuka) for co-development and commercialization in Japan of the oncolytic virus... Read more
CHICAGO – November 29, 2016 – Helium, a critical component in magnetic resonance imaging (MRI) systems, has gone through two potential shortage crises, impacting hospitals and patients around the globe. But the helium supply is finite and demand has been rising over the past decades. At #RSNA16, GE Healthcare (NYSE: GE) proudly unveils Freelium*, a... Read more